• A comparative analysis of chronic inducible urticaria in 423 patients: Clinical and laboratory features and comorbid conditions
• Adult patient diagnosed with Muckle-Wells syndrome, antiphospholipid syndrome and glomerular haematuria
• Anaphylaxis and cold urticaria in an 11-year-old girl
• Anaphylaxis due to legumes: case report
• Beyond visual inspection: The value of infrared thermography in skin diseases, a scoping review
• CANE, a Component of the NLRP3 Inflammasome, Promotes Inflammasome Activation
• Case Report: A <em>de novo NLRP3</em> variant resulting in autoinflammatory disease in a Chinese newborn
• Cerebral infarction after anaphylactic shock due to cold-induced urticaria
• Chronic Inducible Urticaria
• Chronic Urticaria and Angioedema: Masqueraders and Misdiagnoses
• Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment
• Clinical and Genetic Spectrum of Nine Cases of NLRP3-Associated Autoinflammatory Disease (NLRP3-AID) and Identification of One Novel NLRP3 Mutation by Genetic Variation Analyses
• Clinical characteristics of Chinese neonates with neonatal-onset multisystem inflammatory disease: a case report and literature review
• Cold Anaphylaxis in Children: Italian Case Series and Review of the Literature
• Cold hypersensitivity in the hands and feet is associated with erectile dysfunction in young Taiwanese men
• Cold urticaria as a complication of cryotherapy in the treatment of viral warts
• Cold Urticaria Due To Amoxicillin-Clavulanic Acid
• Cold urticaria in tropics: A clinico-epidemiological study from North India
• Cold Urticaria Syndromes: Diagnosis and Management
• Cold urticaria triggered after amoxicillin-clavulanic acid treatment
• Cold Urticaria Triggered After Treatment With Amoxicillin-Clavulanic Acid
• Cold-induced anaphylaxis triggered by drinking cold water
• Cold-induced urticaria after black ant bite anaphylaxis
• Cold-Induced Urticaria in a Paediatric Patient: A Case Report and Literature Review
• Cold-induced urticaria in children: A multicenter, retrospective cohort study
• Cold-induced urticaria-like lesions related to NLRP-12 mutation
• COVID-19 Clinical Features and Outcome in Italian Patients Treated with Biological Drugs Targeting Type 2 Inflammation
• Cracking the NLRP3 code: Pioneering precision medicine for inflammation
• Cryopyrin-associated periodic fever syndrome (CAPS) presenting as early-onset dementia, lacking typical recurrent fever or skin rash: a case report
• Diagnosis traps for patients with acquired NLRP3 mutation
• Early-onset recurrent panniculitis as a phenotype of NLRC4-associated autoinflammatory syndrome: Characterization of pathogenicity of the p.Ser445Pro NLRC4 variant
• Effects of feeding with a protein liquid supplement on productivity, mortality and health of Apis mellifera hives in southwestern Spain
• Effects of the immunoglobulin/histamine complex on panic disorder concurrent with chronic spontaneous urticaria: a case report
• Efficacity of dupilumab in severe idiopathic cold urticaria: a case report
• Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study
• Evaluation of common NLRP3 Q703K variant in pediatric patients with autoinflammatory disease: CAPS and PFAPA
• Exploratory study of cold hypersensitivity in Japanese women: genetic associations and somatic symptom burden
• Expression of MHC II in DRG neurons attenuates paclitaxel-induced cold hypersensitivity in male and female mice
• Genetic variations in NLRP3 and NLRP12 genes in adult-onset patients with autoinflammatory diseases: a comparative study
• Guidelines for cold urticaria management, established by the Centre of Evidence of Dermatology and the Urticaria Group of the French Society of Dermatology
• Hereditary angioedema in Spain: medical care and patient journey
• HSP90β controls NLRP3 autoactivation
• Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency
• Human PLCG2 Haploinsufficiency Results in a Novel NK Cell Immunodeficiency
• Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature
• Identifying high-risk neurological phenotypes in adult-onset classic monogenic autoinflammatory diseases: when should neurologists consider testing?
• Inhibition of interleukin-1 with rilonacept is not effective in cold urticaria-Results of a randomized, placebo-controlled study
• Isoliquiritigenin inhibits NLRP3 inflammasome activation with CAPS mutations by suppressing caspase-1 activation and mutated NLRP3 aggregation
• KCNN4 links PIEZO-dependent mechanotransduction to NLRP3 inflammasome activation
• Lipids in inflammasome activation and autoinflammatory disorders
• Long-term renal outcome of Cryopyrin-associated periodic syndrome (CAPS) under anti-Interleukin-1 therapy
• Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry
• Low-level NLRP3 somatic mosaicism in adult-onset cryopyrin-associated periodic syndrome misdiagnosed as chronic urticaria
• Mycoplasma pneumoniae–Induced Rash and Mucositis (MIRM)
• New insights into chronic inducible urticaria
• NLRC4 gain-of-function variant is identified in a patient with systemic lupus erythematosus
• NLRP12-associated autoinflammatory disease: much more than the FCAS phenotype
• No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice
• Non-invasive load monitoring based on deep learning to identify unknown loads
• Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study
• Omalizumab prevents respiratory illnesses in non-atopic chronic spontaneous urticaria patients: A prospective, parallel-group, pilot pragmatic trial
• Optical coherence tomography assessment of disease activity in cryopyrin-associated periodic syndrome
• Pathogenic NLRP3 mutants form constitutively active inflammasomes resulting in immune-metabolic limitation of IL-1β production
• Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype
• Physical urticaria: Clinical features, pathogenesis, diagnostic work-up, and management
• Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA)
• Predictive factors of quality of life in chronic pruritus patients: A cross-sectional study
• Short-Term Ambient Air Pollution and Urticaria in Guangzhou, China: Estimating the Association and Population Attributable Fraction
• Socio-professional impact and quality of life of cryopyrin-associated periodic syndromes in 54 patients in adulthood
• Splice site and de novo mutations can cause mixed dominant negative/gain of function PLCG2 -associated immune dysregulation with cold urticaria (CU-PLAID)
• Splice site and de novo mutations can cause mixed dominant negative/gain of function PLCG2-associated immune dysregulation with cold urticaria (CU-PLAID)
• Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)
• Subcutaneous administration of a novel TRPM8 antagonist reverses cold hypersensitivity while attenuating the drop in core body temperature
• The genetic and clinical characteristics and effects of Canakinumab on cryopyrin-associated periodic syndrome: a large pediatric cohort study from China
• The pathogenesis of primary acquired cold urticaria
• Topical Oxaliplatin Produces Gain- and Loss-of-Function in Multiple Classes of Sensory Afferents
• Unveiling Treatment Response Predictors in Predominant Subtypes of Chronic Inducible Urticaria